SCHEMBL29944859

SCHEMBL29944859

CCOC(=O)c1cccc(NC(=O)c2sccc2S(=O)(=O)N(C)c2ccc(OCCOC)cc2)c1

nearest known ligand 0.89

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SREBF1 P36956 15/20 0.89
NR1H2 P55055 12/20 0.89
NR1H3 Q13133 12/20 0.89
NPC1 O15118 2/20 0.51
MAPT P10636 2/20 0.51
RAB9A P51151 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
MAPK1 P28482 2/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
HSD17B10 Q99714 1/20 0.48
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27245361 1.00 SREBF1 (0.89) SREBF1NR1H2NR1H3NPC1MAPT
SCHEMBL27030539 0.94 SREBF1 (1.00) SREBF1NR1H2NR1H3NPC1MAPT
SCHEMBL27030601 0.93 SREBF1 (0.89) SREBF1NR1H2NR1H3NPC1MAPT
SCHEMBL27030630 0.90 SREBF1 (0.72) SREBF1NR1H2NR1H3NPC1RAB9A
SCHEMBL27245358 0.89 SREBF1 (0.85) SREBF1NR1H2NR1H3NPC1MAPT
SCHEMBL27245333 0.88 SREBF1 (0.80) SREBF1NR1H2NR1H3NPC1MAPT
SCHEMBL29944868 0.88 SREBF1 (0.80) SREBF1NR1H2NR1H3NPC1MAPT
SCHEMBL29944871 0.87 SREBF1 (0.79) SREBF1NR1H2NR1H3NPC1MAPT
SCHEMBL27245334 0.87 SREBF1 (0.79) SREBF1NR1H2NR1H3NPC1MAPT
SCHEMBL29944856 0.86 NR1H2 (1.00) SREBF1NR1H2NR1H3NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308554-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA The Board of Trustees of the University of Illinois (US) 2024-01-24 EP disclosed
WO-2022197658-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATING TYPE 2 DIABETES AND DEMENTIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-09-22 WO disclosed